These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25379695)
1. p-Synephrine suppresses glucose production but not lipid accumulation in H4IIE liver cells. Cui Z; Lee Y; Lee Y; Park D J Med Food; 2015 Jan; 18(1):76-82. PubMed ID: 25379695 [TBL] [Abstract][Full Text] [Related]
2. p-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells. Hong NY; Cui ZG; Kang HK; Lee DH; Lee YK; Park DB Biochem Biophys Res Commun; 2012 Feb; 418(4):720-4. PubMed ID: 22306011 [TBL] [Abstract][Full Text] [Related]
3. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver. Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089 [TBL] [Abstract][Full Text] [Related]
4. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Stohs SJ; Preuss HG; Shara M Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414 [TBL] [Abstract][Full Text] [Related]
5. The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca(2+)-mobilization and cAMP production. de Oliveira AL; Comar JF; de Sá-Nakanishi AB; Peralta RM; Bracht A Mol Cell Biochem; 2014 Mar; 388(1-2):135-47. PubMed ID: 24287564 [TBL] [Abstract][Full Text] [Related]
6. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium. Mercader J; Wanecq E; Chen J; Carpéné C J Physiol Biochem; 2011 Sep; 67(3):443-52. PubMed ID: 21336650 [TBL] [Abstract][Full Text] [Related]
8. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Stohs SJ; Preuss HG; Shara M Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491 [TBL] [Abstract][Full Text] [Related]
9. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes. Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861 [TBL] [Abstract][Full Text] [Related]
10. Actions of p-synephrine on hepatic enzyme activities linked to carbohydrate metabolism and ATP levels in vivo and in the perfused rat liver. Maldonado MR; Bracht L; de Sá-Nakanishi AB; Corrêa RCG; Comar JF; Peralta RM; Bracht A Cell Biochem Funct; 2018 Jan; 36(1):4-12. PubMed ID: 29270996 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial. Shara M; Stohs SJ; Mukattash TL Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284 [TBL] [Abstract][Full Text] [Related]
13. Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet. Shin EJ; Park JH; Sung MJ; Chung MY; Hwang JT BMC Complement Altern Med; 2016 Dec; 16(1):499. PubMed ID: 27912736 [TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study. Shara M; Stohs SJ; Smadi MM Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542 [TBL] [Abstract][Full Text] [Related]
15. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis]. Perova IB; Eller KI; Musatov AV; Tymolskaya EV Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130 [TBL] [Abstract][Full Text] [Related]
16. Physiological effects following administration of Citrus aurantium for 28 days in rats. Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D; Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485 [TBL] [Abstract][Full Text] [Related]
17. Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake. da Silva-Pereira JF; Bubna GA; Gonçalves Gde A; Bracht F; Peralta RM; Bracht A Food Funct; 2016 Mar; 7(3):1483-91. PubMed ID: 26883936 [TBL] [Abstract][Full Text] [Related]
18. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Stohs SJ; Preuss HG; Shara M Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645 [TBL] [Abstract][Full Text] [Related]
19. Co-Existence of Hypertensive and Anti-Hypertensive Constituents, Synephrine, and Nobiletin in Kim JJ; Kim K; Jung YR; Bian Y; Ngo T; Bae ON; Lim KM; Chung JH Molecules; 2019 Mar; 24(7):. PubMed ID: 30934724 [TBL] [Abstract][Full Text] [Related]
20. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells. Yuan HD; Piao GC Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]